Skip to main content

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

    • Nutraceuticals

      • 2nd Edition
      • January 27, 2021
      • Ramesh C. Gupta + 2 more
      • English
      • Hardback
        9 7 8 0 1 2 8 2 1 0 3 8 3
      • eBook
        9 7 8 0 1 2 8 2 1 2 4 6 2
      Nutraceuticals: Efficacy, Safety and Toxicity, Second Edition, brings together everything that is currently known about nutraceuticals and their potential toxic effects. The book introduces readers to nutraceuticals, herbal medicines, Ayurvedic medicines, prebiotics, probiotics, adaptogens, and their uses and specific applications. This essential reference discusses the mechanism of action for the judicious use of these nutraceuticals and the best tools for their evaluation before detailing the safety and toxicity of nutraceuticals and interactions with other therapeutic drugs. Finally, and crucially, regulatory aspects from around the world are covered. Completely revised and updated, this updated edition provides toxicologists, pharmacologists, pharmaceutical scientists, and those interested in medicinal plants and natural products with a comprehensive overview of the most effective tools upon which to evaluate the safety and toxicity of nutraceuticals, prebiotics, probiotics and alternative medicines.
    • Inflammation and Natural Products

      • 1st Edition
      • January 19, 2021
      • Sreeraj Gopi + 3 more
      • English
      • Paperback
        9 7 8 0 1 2 8 1 9 2 1 8 4
      • eBook
        9 7 8 0 1 2 8 1 9 2 1 9 1
      Inflammation and Natural Products brings together research in the area of the natural products and their anti-inflammatory action in medical, nutraceutical and food products, addressing specific chronic inflammatory diseases like cancer and the mechanistic aspects of the mode of action of some key natural products. Inflammation is a complicated process, driven by infection or injury or genetic changes, which results in triggering signalling cascades, activation of transcription factors, gene expression, increased levels of inflammatory enzymes, and release of various oxidants and pro-inflammatory molecules in inflammatory cells. Excessive oxidants and inflammatory mediators have a harmful effect on normal tissue, including toxicity, loss of barrier function, abnormal cell proliferation, inhibiting normal function of tissues and organs and finally leading to systemic disorders. The emerging development of natural product formulations utilizing the unique anti-inflammatory compounds such as polyphenols, polysaccharides, terpenes, fatty acids, proteins and several other bioactive components has shown notable successes. Inflammation and Natural Products: Recent Development and Current Status provides a comprehensive resource, ranging from detailed explanation on inflammation to molecular docking strategies for naturally occurring compounds with anti-inflammatory activity. It is useful for graduate students, academic and professionals in the fields of pharmaceutical and medical sciences and specialists from natural product-related industries.
    • Prof. of Drug Substances, Excipients and Related Methodology

      • 1st Edition
      • Volume 46
      • January 16, 2021
      • Abdulrahman Al-Majed
      • English
      • Hardback
        9 7 8 0 1 2 8 2 4 1 2 7 1
      • eBook
        9 7 8 0 1 2 8 2 4 1 2 8 8
      Profiles of Drug Substances, Excipients, and Related Methodology, Volume 46 contains comprehensive profiles of five drug compounds: Darunavir, Bisoprolol, Betaxolol, Rabeprazole and Irbesartan. In addition, the work contains a chapter reviewing Bioassay Methods and Their Applications in Herbal Drug Research. The comprehensive reviews in the book cover all aspects of drug development and the formulation of drugs, helping readers understand how the drug development community remains essential to all phases of pharmaceutical development. In addition, this work answers why such profiles are of immeasurable importance to workers in the field. The scope of the Profiles series encompasses review articles and database compilations that fall within one or more of the following five broad categories: Physical Profiles of Drug Substances and Excipients, Analytical Profiles of Drug Substances and Excipients, ADME Profiles of Drug Substances and Excipients, Methodology Related to the Characterization of Drug Substances and Excipients, and Methods of Chemical Synthesis.
    • Considering the Patient in Pediatric Drug Development

      • 1st Edition
      • November 19, 2020
      • Klaus Rose
      • English
      • Paperback
        9 7 8 0 1 2 8 2 3 8 8 8 2
      • eBook
        9 7 8 0 1 2 8 2 4 2 0 5 6
      Considering the Patient in Pediatric Drug Development: How Good Intentions Turned into Harm addresses a fundamental challenge in drug development and healthcare for young patients. In clinical trials and clinical practice, the term "children" is used ambiguously to confer physiological characteristics to a chronological age limit, which in reality does not exist. This book outlines why the United States (US) and European Union's (EU) regulatory authorities, pediatric academia, and the pharmaceutical industry demand, support and perform pediatric drug studies, along with the key flaws of this demand that blurs the different administrative and physiological meanings of the term "child." In addition, the book covers why most pediatric regulatory studies lack medical sense and many even harm young patients and the conflicts of interest behind pediatric drug studies. It includes relevant information about the maturation of the human body regarding absorption, distribution, metabolism and excretion of food and drugs as well as key differences between newborns, infants, older children and adolescents.
    • Naturally Occurring Chemicals against Alzheimer’s Disease

      • 1st Edition
      • November 19, 2020
      • Tarun Belwal + 4 more
      • English
      • Paperback
        9 7 8 0 1 2 8 1 9 2 1 2 2
      • eBook
        9 7 8 0 1 2 8 1 9 2 1 3 9
      Naturally Occurring Chemicals against Alzheimer’s Disease offers a detailed discussion on the roles, molecular mechanisms, structural activity relationships, toxicology and clinical data on phytochemicals in relation to Alzheimer’s disease. The book examines the available phytochemicals and plants that are potentially effective, also determining the role and molecular targets of these phytochemicals in combating AD. This comprehensive resource will be helpful to researchers who are working on herbal drugs on AD, phytochemistry, pharmacology, toxicology, clinical trials, neuroscience and advancement in formulations.
    • Drug Delivery Devices and Therapeutic Systems

      • 1st Edition
      • November 7, 2020
      • Eric Chappel
      • English
      • Paperback
        9 7 8 0 1 2 8 1 9 8 3 8 4
      • eBook
        9 7 8 0 1 2 8 1 9 8 3 9 1
      Drug Delivery Devices and Therapeutic Systems examines the current technology and innovations moving drug delivery systems (DDS) forward. The book provides an overview on the therapeutic use of drug delivery devices, including design, applications, and a description of the design of each device. While other books focus on the therapy, the primary emphasis in this book is on current technologies for DDS applications, including microfluidics, nanotechnology, biodegradable hydrogel and microneedles, with a special emphasis on wearable DDS. As part of the Developments in Biomedical Engineering and Bioelectronics series, this book is written by experts in the field and informed with information directly from manufacturers. Pharmaceutical scientists, medical researchers, biomedical engineers and clinical professionals will find this an essential reference.
    • Medicinal Plants in Asia and Pacific for Parasitic Infections

      • 1st Edition
      • October 20, 2020
      • Christophe Wiart
      • English
      • Paperback
        9 7 8 0 1 2 8 1 6 8 1 1 0
      • eBook
        9 7 8 0 1 2 8 1 6 8 1 2 7
      Medicinal Plants in Asia and Pacific for Parasitic Infections: Botany, Ethnopharmacology, Molecular Basis, and Future Prospect offers an in-depth view into antiprotozoal pharmacology of natural products from medicinal plants in Asia with an emphasis on their molecular basis, cellular pathways, and cellular targets. This book provides scientific names, botanical classifications, botanical description, medicinal uses, chemical constituents and antiprotozoal activity of more than 100 Asian medicinal plants, with high quality original botanical plates, chemical structures, and pharmacological diagrams and lists hundreds of carefully selected references. It also examines the pharmacological and medicinal applications of Asian medicinal plants especially in drug development for protozoan prevention and treatment. Medicinal Plants in Asia and Pacific for Parasitic Infections is a research tool and resource for the discovery of leads for the treatment of protozoal diseases based on interrelated botanical, biochemical, ethnopharmacological... phylogenetic, pharmacological, and chemical information.
    • Medicinal Natural Products: A Disease-Focused Approach

      • 1st Edition
      • Volume 55
      • September 21, 2020
      • English
      • Hardback
        9 7 8 0 1 2 8 2 1 0 1 9 2
      • eBook
        9 7 8 0 1 2 8 2 1 0 2 0 8
      Medicinal Natural Products: A Disease-Focused Approach, Volume 55 in the Annual Reports in Medicinal Chemistry series, highlights the applications of natural products as medicines or prospective medicinal leads for the treatment of various human ailments. Each chapter covers a particular disease area or medical condition, with chapters in this new release covering Medicinal Natural Products – An Introduction, Anticancer Natural Products, Antimicrobial Natural Products, Antimalarial and Antiparasitic Natural Products, Anti-inflammatory Natural Products, Neuroprotective Natural Products, Hepatoprotective Natural Products, Nephroprotective Natural Products, Cancer Chemopreventive Natural Products, Antipsoriatic Natural Products, Medicinal Natural Products in Osteoporosis, Antidiabetic Natural Products, Anti-obesity Natural Products, and much more.
    • Rapid Acting Antidepressants

      • 1st Edition
      • Volume 89
      • June 26, 2020
      • English
      • Hardback
        9 7 8 0 1 2 8 2 0 1 8 9 3
      • eBook
        9 7 8 0 1 2 8 2 0 1 9 0 9
      The Advances in Pharmacology series presents a variety of chapters from the best authors in the field.
    • Drug Safety in Developing Countries

      • 1st Edition
      • June 3, 2020
      • Yaser Mohammed Al-Worafi
      • English
      • Paperback
        9 7 8 0 1 2 8 1 9 8 3 7 7
      • eBook
        9 7 8 0 1 2 8 2 0 4 1 2 2
      Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries.